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Development of a Nanobody-based 
lateral flow assay to detect active 
Trypanosoma congolense infections
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Vertommen4, Peter Naniima6, Rui Chen3, Serge Muyldermans  1, Yann G.-J. Sterckx1,2 & 
Stefan Magez1,2,5
Animal African trypanosomosis (AAT), a disease affecting livestock, is caused by parasites of the 
Trypanosoma genus (mainly T. vivax and T. congolense). AAT is widespread in Sub-Saharan Africa, 
where it continues to impose a heavy socio-economic burden as it renders development of sustainable 
livestock rearing very strenuous. Active case-finding and the identification of infected animals prior to 
initiation of drug treatment requires the availability of sensitive and specific diagnostic tests. In this 
paper, we describe the development of two heterologous sandwich assay formats (ELISA and LFA) for 
T. congolense detection through the use of Nanobodies (Nbs). The immunisation of an alpaca with a 
secretome mix from two T. congolense strains resulted in the identification of a Nb pair (Nb44/Nb42) 
that specifically targets the glycolytic enzyme pyruvate kinase. We demonstrate that the Nb44/Nb42 
ELISA and LFA can be employed to detect parasitaemia in plasma samples from experimentally infected 
mice and cattle and, additionally, that they can serve as ‘test-of-cure’ tools. Altogether, the findings 
in this paper present the development and evaluation of the first Nb-based antigen detection LFA to 
identify active T. congolense infections.
Animal African trypanosomosis (AAT) is a neglected tropical disease caused by parasites of the Trypanosoma 
genus and mainly affects livestock in Sub-Saharan Africa. AAT is hallmarked by a mild to severe pathology in 
large and small ruminants, which results in drastic reductions of draft power, meat and milk production by the 
infected animals. It is believed that approximately 50 million livestock animals across Sub-Saharan Africa are 
currently at risk of infection. Thus, AAT has both direct and indirect consequences on the socio-economic devel-
opment of the endemic areas with yearly losses estimated in the order of magnitude of billion USD1,2. The most 
important causative Trypanosoma species for AAT are T. congolense, T. vivax and, to a lesser extent, T. brucei 
brucei3,4. In many rural regions, the prevalence of T. congolense and T. vivax infections is prominent (20–40%) 
and mixed infections have been reported to be quite common5,6. Prevention of AAT requires the concerted action 
of vector control programs7,8 and drug treatment schemes9, especially since vaccine development experiences 
major hurdles10,11. The success of prevention and control initiatives heavily depends on the availability of accurate, 
sensitive and specific diagnostic methods. Unfortunately, most tests currently employed in endemic areas do not 
meet the required standards. In many cases, cattle are treated based on symptoms, which have the problem of not 
being pathognomonic. While the situation has been improved by the advent of microscopic methods such as the 
hematocrit technique12,13, the sensitivity and specificity of these assays remain relatively low. The lack of routine 
field diagnosis has resulted in the indiscriminate use (and misuse) of trypanocidal drugs, thereby accelerating the 
rise of parasite resistance14–16. The situation is further complicated by the circulation of counterfeit products17 and 
drug administration by farmers themselves because of limited veterinary assistance18.
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Within a healthcare context, the development of so-called ‘rapid diagnostic tests (RDTs)’ is of primary inter-
est. RDTs are diagnostic assays from which the results are available within a short time such that control and 
treatment strategies may be initiated as soon as possible. The ideal RDT to be used under field conditions has 
to meet the requirements of the ‘ASSURED’ principle: affordable by those at risk of infection, sensitive, specific, 
user-friendly, rapid and robust, equipment-free, and delivered to those in need19. Diagnosis of trypanosomes is 
either based on the detection of parasite molecules (DNA and protein) or host antibodies against parasite anti-
gens. Recently, the sensitivity and specificity of AAT diagnosis have greatly been improved by the development of 
DNA-based assays such as PCR and LAMP, which aim to amplify parasite DNA20–24. While such assays are highly 
reliable and have the potential of detecting an infection before the manifestation of pathology, their deploy-
ment in the field is generally difficult. Indeed, PCR requires a laboratory environment and trained personal and 
LAMP could be prone to contamination during sample preparation in the field25,26. Furthermore, it is has been 
documented that livestock rearing communities heavily burdened by AAT rarely call upon trained personnel 
to perform diagnosis and drug treatment27. Hence, DNA-based diagnostic tests do not yet meet all ASSURED 
criteria. Serological immunoassays (such as enzyme-linked immunosorbent assays; ELISA), which either detect 
host antibodies against parasite antigens (antibody-based assays) or parasite antigens directly (antigen-based 
assays), may represent interesting starting points for RDT development. These rely on the formation of specific 
antibody-antigen complexes and can be translated into lateral flow assays (LFAs).
Both antibody- and antigen-based formats have their advantages and drawbacks. Antibody-based assays, of 
which the sensitivity relies on the magnitude of the host’s humoral response, have two potential flaws: (i) a low 
specificity due to antibody cross-reactivity28, and (ii) the occurrence of long lasting antibodies that remain in cir-
culation weeks to months after clearance of infection, thereby making the identification of active infections unre-
liable6,29,30. Several antibody-based immunoassays have been developed for T. congolense and T. vivax31–35. While 
some of them have been successfully deployed in large-scale surveys31,32,35, one has recently been commercial-
ised35,36. T. congolense specific antigen-based ELISAs have also been described37,38. Although antigen-based immu-
noassays do not experience the aforementioned issues, they are not flawless. Since the sensitivity of antigen-based 
assays is mainly determined by the amount of circulating parasite antigen, the latter should be high enough to be 
detected39. Additionally, the target antigen should possess epitopes specific to a given parasite genus or even spe-
cies. The capturing and detecting antibodies constituting the assay may either recognise the same (homologous) or 
distinct (heterologous) epitopes, thereby imposing additional requirements on the nature of the antigen depend-
ing on the used set-up: while the antigen does not have to be a multimer or monomer with repeating epitopes 
for detection in heterologous systems, this is a necessity in the case of homologous antigen-based assays40–42. 
Also, the assay’s antibodies must be able to outcompete host antibodies or bind different epitopes39 to avoid false 
negative scores and must not interact directly with host anti-IgG antibodies to avoid false positive signals (this 
occurs generally through interactions with the constant Fc domains43). These pitfalls could be avoided by the use 
of Nanobodies (Nbs) as primary reagents in the immunoassays. Nbs are small antigen-binding entities (15 kDa) 
corresponding to the variable domains of camelid heavy-chain only antibodies44,45. First, Nbs have the potential to 
recognise epitopes distinct from those targeted by conventional antibodies46,47. Second, these single-domain anti-
body fragments do not possess an Fc domain, thereby reducing the likelihood of non-specific interactions with 
host antibodies. Finally, Nbs can easily be tailored into multivalent and/or tagged constructs48 and can be coated 
onto gold nanoparticles (AuNPs)41,49, which adds to their versatility as detection tools for LFA use.
The application of a Nb-based sandwich ELISA for the specific detection of T. congolense infections has 
recently been described42. Despite the assay’s decent performance on fresh field samples (sensitivity and spec-
ificity of 87% [95% CI, 73–95%] and 94% [95% CI, 71–100%], respectively), its translation into an LFA will be 
difficult due to its homologous set-up. In this paper, we describe the development of a Nb-based T. congolense 
specific heterologous sandwich ELISA and its translation into an LFA. Two Nbs, Nb42 and Nb44, were iden-
tified by immunising an alpaca with T. congolense secretome, which constitutes the proteome fraction that is 
actively secreted by the parasite in the host’s blood stream. We demonstrate that the Nb44/Nb42 pair specifically 
recognises T. congolense pyruvate kinase (TcoPYK), thereby validating yet another glycolytic enzyme as a can-
didate biomarker. Using these Nbs, we have developed antigen-based immunoassays in two formats: a heterol-
ogous sandwich ELISA and an LFA prototype. We discuss assay optimisation and show that both can be used as 
test-of-cure tools in experimental infections in mice. Finally, we present a preliminary evaluation of the perfor-
mance of the LFA on plasma samples from experimentally infected cattle.
Results
An anti-T. congolense secretome Nb library yields a Nb pair (Nb44/Nb42) specific for T. congo-
lense. An anti-T. congolense secretome Nb library was generated by immunising an alpaca with a mixture of 
the secretomes of T. congolense strains IL1180 and IL3000 (Supplementary Fig. S1). The panning strategy adopted 
in this work resulted in the identification of five distinct Nbs. All Nbs were tested for their potential to recognise 
T. congolense secretome in a sandwich ELISA. In this set-up, the capturing Nbs are His-tagged (NbH), whereas 
the detecting Nbs possess an HA-tag (NbHA). Every possible Nb pair was tested on T. congolense infected mouse 
serum, leading to 25 combinations. From Fig. 1a it can be seen that two Nb pairs result in a clear signal: Nb42/
Nb42 and Nb44/Nb42. As the goal of the work was to develop a heterologous sandwich assay (i.e., capturing and 
detecting Nb must differ), only the Nb44/Nb42 pair was considered. Interestingly, the roles of these two Nbs in 
the heterologous sandwich cannot be inverted, as the Nb42/Nb44 combination yields no signal (Fig. 1a).
The specificity of the Nb44/Nb42 pair was verified by testing sera from mice infected with various Trypanosoma 
and one Leishmania species. T. congolense secretome samples and naive mouse sera were employed as positive and 
negative controls, respectively. Only T. congolense infections provide positive signals, albeit with varying intensities 
depending on the strain (Fig. 1b). Infections with other trypanosomatids did not result in any detection.
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The Nb44/Nb42 pair targets T. congolense pyruvate kinase. Next, the identification of the parasite 
antigen targeted by the Nb44/Nb42 pair was ensued. To this end, an immuno-capturing experiment was com-
bined with mass spectrometry. SDS-PAGE analysis of an immuno-capturing with Nb42 on T. congolense IL3000 
secretome shows the occurrence of a single protein band with a molecular mass between 55 kDa and 70 kDa in the 
captured fraction. Mass spectrometry on the excised band identifies the target as T. congolense pyruvate kinase 
(Uniprot ID: G0UYF4), a well-known and well-conserved glycolytic enzyme (Fig. 1c).
To verify that the Nb44/Nb42 pair specifically targets T. congolense pyruvate kinase, the sandwich ELISA 
was performed with recombinant T. congolense pyruvate kinase (TcoPYK), T. brucei brucei pyruvate kinase 
(TbrPYK), and L. mexicana pyruvate kinase (LmePYK). The production in and purification from E. coli of these 
Figure 1. An anti-T. congolense secretome Nb library yields a Nb pair (Nb44/Nb42) that targets T. congolense 
pyruvate kinase. (a) Heat map representation of the results of the sandwich ELISA pairing assay performed 
with the five Nbs retrieved from the T. congolense secretome library (Nb20, Nb25, Nb42, Nb44 and Nb45). 
In this set-up, the capturing Nbs carry a C-terminal hexahistidine tag (denoted by the suffix ‘H’), while the 
detecting Nbs harbour a haemagglutinin tag followed by a hexahistidine tag at their C-terminus (denoted 
by the suffix ‘HA’). (b) Heterologous sandwich ELISA using the Nb44/Nb42 pair to determine its specificity. 
The sera from mice infected with various Trypanosoma and one Leishmania species were tested. T. congolense 
secretome samples and naive mouse sera were employed as positive and negative controls, respectively. (c) The 
top panel displays the Nb42H immuno-capturing experiment. T. congolense secretome was allowed to interact 
with nickel beads loaded with Nb42H. After a washing step, the captured protein was eluted and analysed 
on a 10% SDS-PAGE developed with Coomassie blue. Lane M, Prestained Protein Molecular Weight Marker 
(ThermoFischer Scientific); Lane 1, Nb42H; Lane 2, secretome flow through; Lane 3, wash; Lane 4, eluted 
protein. Native TcoPYK and Nb42H migrate at ~56 kDa and ~15 kDa and are indicated by green and brown 
arrows, respectively. The bottom panel shows the results of the MS analysis on the TcoPYK protein band. The 
detected peptides are highlighted in green. MS analysis recovered several peptides covering up to 64.13% of the 
entire TcoPYK sequence. (d) A heterologous sandwich ELISA on recombinant TcoPYK, TbrPYK, and LmePYK 
demonstrates that the Nb44/Nb42 pair is specific for TcoPYK.
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three enzymes is described in Supplementary Fig. S2. As can be seen from Fig. 1d, the Nb44/Nb42 pair only yields 
a positive signal for TcoPYK, thereby confirming the target’s identity and the assay’s specificity.
Nb42 and Nb44 recognise distinct epitopes on T. congolense pyruvate kinase. Before further 
development of the Nb44/Nb42 immunoassay, the interactions of both Nbs with TcoPYK were characterised 
through a combination of surface plasmon resonance (SPR) and analytical size exclusion chromatography (SEC).
The Nb-TcoPYK interactions were first investigated by SPR. For the Nb42:TcoPYK complex, a data set was 
collected according to the standard format (Fig. 2a), while for Nb44 data for the interaction with TcoPYK were 
recorded in the format of a kinetic titration50 (Fig. 2b) due to the absence of a suitable regeneration condition. 
Analysis of the SPR data with a 1:1 binding model reveals that the Nb-TcoPYK interactions have affinities in the 
nM range, with Nb42 exhibiting the tightest binding (Fig. 2, panels a and b).
Figure 2. Nb42 and Nb44 recognise distinct epitopes on T. congolense pyruvate kinase. (a,b) SPR data recorded 
for the Nb42-TcoPYK (a) and Nb44-TcoPYK (b) interactions with the Nbs as ligands and TcoPYK as the analyte. 
The top panels display the sensorgrams (black traces) and the fit to the data with a 1:1 Langmuir binding model 
(red traces). The residuals of the fit are shown in the bottom panels. (c–f) Investigation of the formation of a 
tripartite (Nb44)2: (TcoPYK)4: (Nb42)4 complex via analytical SEC: TcoPYK (c) Nb44 (d) Nb42 (e) and Nb42 
mixed with the preformed Nb44:TcoPYK complex in the correct stoichiometric amounts (f). All experiments 
were performed on an ENRICH 650 10/30 column. The black and grey traces represent the chromatograms 
of the different protein samples and the BioRAD gel filtration standard, respectively. In all figures, the inset 
shows an SDS-PAGE analysis of the elution peaks. TcoPYK (MM = 56.2 kDa), Nb44 (MM = 14.3 kDa), and 
Nb42 (MM = 16.4 kDa) are indicated by the green and brown arrows, respectively. Lane M, Prestained Protein 
Molecular Weight Marker (ThermoFischer Scientific).
www.nature.com/scientificreports/
5ScIentIfIc REPORts |  (2018) 8:9019  | DOI:10.1038/s41598-018-26732-7
Next, a titration experiment monitored by analytical SEC was carried out to determine the stoichiometries 
of the Nb42:TcoPYK and Nb44:TcoPYK complexes. As expected for pyruvate kinases51, TcoPYK behaves as a 
tetramer (Supplementary Figs S3 and S4). Interestingly, the Nb42:TcoPYK and Nb44:TcoPYK complexes display 
distinct stoichiometries (4:4 and 2:4, respectively). While a single TcoPYK tetramer can bind 2 Nb44 molecules, 
4 binding sites are available for Nb42 (Supplementary Figs S3 and S4). This suggests that Nb44 and Nb42 rec-
ognise distinct, non-competing epitopes on TcoPYK. To verify this hypothesis, analytical SEC was employed to 
assess whether a tripartite (Nb44)2: (TcoPYK)4: (Nb42)4 complex could be formed. Because of the unidirectional 
character of TcoPYK binding by the Nbs, Nb44 was allowed to interact with TcoPYK prior to Nb42 during sample 
preparation. The results demonstrate that the tripartite (Nb44)2: (TcoPYK)4: (Nb42)4 complex elutes as a single 
peak containing all three proteins indicating that Nb44 and Nb42 do not compete for the same TcoPYK epitope 
(Fig. 2, panels c through f). These findings provide evidence that both Nbs bind distinct epitopes on TcoPYK, 
thereby advocating their further use in the development of a heterologous sandwich ELISA and LFA.
Optimisation of the Nb44/Nb42 ELISA assay buffer counteracts the plasma matrix effect. To 
determine those Nb44 and Nb42 amounts yielding the highest ELISA signal, a checkerboard format was 
employed and tested on PBS spiked with TcoPYK. As can be seen from Supplementary Fig. S5, the amount of 
Nb44 has the largest influence on the ELISA’s read-out. Upon testing the Nb44/Nb42 ELISA on naive mouse 
serum spiked with TcoPYK, a so-called ‘plasma matrix effect’ was observed. A ‘plasma matrix effect’ is defined as 
“the direct or indirect alteration or interference in response due to the presence of unintended analytes (for analysis) 
or other interfering substances in the sample”52,53. Indeed, from Fig. 3a it is clear that the sensitivity of the assay 
drops significantly when the query sample consists of naive mouse serum spiked with TcoPYK. In an attempt to 
overcome this effect, the spiked mouse serum was diluted in various buffers and subsequently evaluated in the 
Nb44/Nb42 immunoassay. The best results are obtained when the spiked serum samples are diluted 3-fold in PBS 
containing 1% Tween20, indicating that the inclusion of a non-ionic detergent in the reaction mixture alleviates 
the plasma matrix effect (Fig. 3b).
The versatility of Nbs can be exploited to improve the performance of the Nb42/Nb44 ELISA. 
Further optimisation of the Nb44/Nb42 ELISA consisted of reducing the number of assay steps (and hence, assay 
time). This was achieved by generating a biotinylated version of Nb42 (Nb42B), which can directly be detected via 
a streptavidin-enzyme conjugate (streptavidin-horse radish peroxidase; strep-HRP) thereby omitting one assay 
step compared to the set-up with Nb42HA (which entails an additional incubation with biotinlyated anti-HA 
mouse monoclonal). When tested on naive mouse serum spiked with TcoPYK, the Nb44/Nb42B/strep-HRP com-
bination yields a limit of detection (LoD) of around 16 ng ml−1 (Fig. 4a). Next, to amplify the ELISA signal upon 
assay development, strep-HRP was replaced by strep-polyHRP, which constitutes of streptavidin conjugated with 
polymers of HRP. This modification to the protocol enhanced the LoD to 2 ng ml−1 (Fig. 4b). Finally, Nb44 was 
tailored in an attempt to improve the ELISA’s LoD. From Supplementary Fig. S5 it is clear that the amount of Nb44 
limits the assay’s sensitivity. Given that Nb44 has a lower affinity for TcoPYK compared to Nb42 as determined via 
SPR (Fig. 2), it was reasoned that employing a bivalent version of Nb44 (Nb44-Nb44) as a capturing agent would 
increase the sensitivity of the assay. Indeed, a comparison between the Nb44/Nb42 and Nb44-Nb44/Nb42 for-
mats reveals that the use of Nb44-Nb44 as a capturing agent markedly improves the LoD to ~0.5 ng ml−1 (Fig. 4, 
panels c and d).
Figure 3. Optimisation of the Nb44/Nb42 ELISA assay buffer counteracts the plasma matrix effect. (a) Nb44/
Nb42 ELISA tested on PBS and naive mouse plasma spiked with TcoPYK at a concentration of 1 μg ml−1. 
(b) Nb44/Nb42 ELISA tested on naive mouse plasma spiked with TcoPYK at a concentration of 1 μg ml−1 
and diluted three-fold in various assay buffers (A: PBS, B: PBS + 100 mM NaCl, C: PBS + 300 mM NaCl, D: 
PBS + 0.5% Tween20, E: PBS + 1.0% Tween20).
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In conclusion, the versatility of Nbs allowed a 32-fold enhancement of the ELISAs LoD. The final format 
employs bivalent Nb44-Nb44H as a capturing agent, monovalent Nb42B for detection, and strep-polyHRP for 
assay development. This Nb44-Nb44/Nb42 ELISA was evaluated as such in mouse infection trials (see below).
The Nb44/Nb42 pair forms the basis for a T. congolense specific LFA. Since Nb42 and Nb44 recog-
nise distinct TcoPYK epitopes, the two Nbs were employed to develop a T. congolense specific LFA. Because of the 
unidirectional character of target antigen binding by the Nb44/Nb42 pair, the capturing and detecting roles of the 
two Nbs have to be inverted compared to the sandwich ELISA set-up. While in a sandwich ELISA the capturing 
agent interacts with the target antigen prior to the detecting agent, this is no longer true in an LFA (i.e. the detect-
ing agent interacts with the target antigen before the capturing agent). Thus, in the LFA format, Nb44 and Nb42 
act as detecting and capturing agents, respectively, instead of vice versa as for the sandwich ELISA (Fig. 5a). The 
LFA control line consists of goat monoclonal anti-rabbit IgG which recognises rabbit polyclonal IgG AuNPs that 
are also applied to the conjugate pad with the Nb44-AuNPs since a monoclonal anti-Nb is currently not available.
Figure 4. The versatility of Nbs can be exploited to improve the performance of the Nb42/Nb44 ELISA. Nb44/
Nb42 ELISA tested on naive mouse serum spiked with a dilution series of TcoPYK using monovalent Nb44H 
for capturing, biotinylated Nb42B for detection, and strep-HRP for assay development (a) monovalent Nb44H 
for capturing, biotinylated Nb42B for detection, and strep-polyHRP for assay development (b) bivalent Nb44-
Nb44H for capturing, biotinylated Nb42B for detection, and strep-HRP for assay development (c) and bivalent 
Nb44-Nb44H for capturing, biotinylated Nb42B for detection, and strep-polyHRP for assay development 
(d). The dashed line displays the ELISA LoD (LoD = meanblank + 3.3 * SDblank). The concentration of TcoPYK 
represents the concentration prior to 3-fold dilution into the assay buffer.
www.nature.com/scientificreports/
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The Nb44/Nb42 LFA effectively detects TcoPYK in PBS with a visual LoD of ~880 ng ml−1 (Fig. 5b). The sen-
sitivity could further be increased by immobilising Nb42B on a streptavidin-coated test line (Fig. 5c). The LFA 
was also tested on plasma samples from naive mice spiked with various amounts of TcoPYK. The initial visual 
LoD (Fig. 5d) was further improved by optimising the conditions under which the Nbs and antigen are allowed 
to interact. This was performed by taking two parameters into account: (i) the sample viscosity, which influences 
the sample flow speed and thus contact time between the Nbs and TcoPYK, and (ii) the plasma matrix effect, 
which can have a negative impact on antigen detection as described earlier for the heterologous sandwich ELISA. 
An assay buffer was designed to simultaneously reduce both the sample flow speed and plasma matrix effects. 
The final assay buffer contains 1% methylcellulose (a component that increases the sample’s viscosity) and 1% 
Tween20 (which deals with the matrix effect as observed previously). As can be seen from Fig. 5e, a significant 
improvement in detection is obtained when naive mouse plasma spiked with TcoPYK is diluted three-fold in the 
assay buffer containing both components (visual LoD of around 14 ng ml−1).
The final LFA format employs Nb44-AuNPs for detection, Nb42B on a streptavidin-coated test line as cap-
turing agent, and requires a 3-fold dilution of the query sample in PBS containing 1% methylcellulose and 1% 
Tween20. This Nb44/Nb42 LFA was evaluated as such in mouse and cattle infection trials (see below).
The Nb44-Nb44/Nb42 ELISA and Nb44/Nb42 LFA can be used as test-of-cure tools during 
experimental T. congolense infections in mice. Both Nb-based assays were evaluated for their potential 
to differentiate between ongoing and past infections in an experimental mouse model. In a first step, the correla-
tion between antigenaemia and parasitaemia was determined by examining blood samples taken from C57BL6/C 
mice (n = 9) infected with T. congolense Tc13 at various time points using the Nb44-Nb44/Nb42 ELISA and 
Figure 5. Generation of a Nb-based LFA for detection of T. congolense. (a) Schematic representation of the 
Nb44/Nb42 sandwich ELISA (left panel) and Nb44/Nb42 LFA (right panel). In both panels, the T. congolense 
antigens are coloured in green, while the Nbs are shown in brown. IgGs are displayed in light (rabbit 
polyclonal) and dark (goat monoclonal) grey. The AuNPs are shown as yellow circles and are not drawn to 
scale with the Nbs and IgGs. (b–e) LFA read-outs for (b) PBS spiked with a dilution series of TcoPYK using 
direct coating of Nb42 on the TL, (c) PBS spiked with a dilution series of TcoPYK using streptavidin-based 
coating of biotinylated Nb42 on the TL, (d) naive mouse serum spiked with a dilution series of TcoPYK 
(streptavidin-based coating of biotinylated Nb42 on the TL) and (e) naive mouse serum spiked with a dilution 
series of TcoPYK and diluted three-fold in PBS containing 1% methylcellulose and 1% Tween20 (streptavidin-
based coating of biotinylated Nb42 on the TL). The visual LoD was established based on the last TcoPYK 
concentration at which a TL band could be observed (indicated by the black arrow). 50 μl of sample was spotted 
onto the sample pad.
www.nature.com/scientificreports/
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Nb44/Nb42 LFA (antigenaemia) and microscopy (parasitaemia). The ELISA and LFA scored positive for most 
infected mice and correlated relatively well with parasitaemia during the course of the infection (Fig. 6a). The 
positive score rates for LFA and microscopy were similar (although both did not always score negative on the 
same samples), while the positive score rate for ELISA was higher through-out the entire follow-up (Table 1).
Figure 6. The Nb44-Nb44/Nb42 ELISA and Nb44/Nb42 LFA can be used as test-of-cure tools during 
experimental T. congolense infections in mice. (a) The detection of target antigen via the Nb44-Nb44/Nb42 
ELISA and Nb44/Nb42 LFA correlate well with parasitaemia. The top panel displays the parasitaemia as 
determined by microscopy monitored over the course of the infection in C57BL6/C mice infected with T. 
congolense Tc13 (n = 9). The middle panel shows the antigenaemia observed by the Nb44-Nb44/Nb42 ELISA. 
The mean values for parasitaemia and antigenaemia are represented by the green line with light green fill. The 
dashed line displays the ELISA detection cut-off value. The bottom panel shows the results of the LFA read-outs 
on the infected mice. (b–d) C57Bl6/C mice infected with T. congolense Tc13 were divided into three groups 
(Group 1 (n = 5), left untreated; Group 2 (n = 5), treated with Berenil at 6 dpi; Group 3 (n = 5), treated with 
Berenil at 14 dpi) and antigenaemia and parasitaemia were followed over time. The results for Group 1, Group 2, 
and Group 3 are shown in panels (b–d), respectively. The panels and colour codes are the same as for panel (a).
Microscopy Microscopy LFA
ELISA (−) (+) LFA (−) (+) ELISA (−) (+)
(−) 9 1 (−) 10 5 (−) 10 0
(+) 4 65 (+) 3 61 (+) 5 64
Kappa ± 95% CI 
0.746 ± 0.211
Kappa ± 95% CI 
0.653 ± 0.221
Kappa ± 95% CI 
0.764 ± 0.195
Table 1. Kappa coefficient analysis of the correlation between the employed diagnostic methods (microscopy, 
ELISA, LFA).
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In a ‘test-of-cure’ experiment, mice infected with T. congolense Tc13 were divided into three groups and anti-
genaemia and parasitaemia were followed over time. Group 1 (n = 5) was left untreated, while Groups 2 and 3 
(both n = 5) were treated with Berenil at 6 and 14 days post-infection, respectively. As expected Group 1 samples 
display a similar behaviour as observed previously (Fig. 6b). After Berenil drug treatment of the infected mice 
(Groups 2 and 3), no TcoPYK could be detected in most cases suggesting that the target antigen disappears from 
the blood stream as soon as 24 hours post-treatment, coinciding with parasite clearance (Fig. 6, panels c and d). 
Only a single mouse in Group 3 had persistent parasitaemia, which could also be detected by the Nb44-Nb44/
Nb42 ELISA.
The Nb44/Nb42 LFA can be employed to detect experimental T. congolense infections in cattle. 
The diagnostic performance of the Nb44/Nb42 LFA was examined by testing stored plasma samples from naive 
Holstein cows (n = 15) and Holstein cows experimentally infected with T. vivax STIB 719 (n = 22) and T. congo-
lense KONT 2/133 (n = 24). Based on the collected data, the LFA’s preliminary sensitivity and specificity, positive 
predictive value (PPV), and negative predictive value (NPV) were calculated (Table 2).
In an effort to further optimise the LFA’s performance on cattle samples, its visual LoD was examined on naive 
bovine plasma spiked with TcoPYK. Compared to mice plasma samples (Fig. 5e), the visual LoD in this case was 
inferior and differed ~60-fold (Fig. 7a). The observed reduced performance of the LFA is probably due to plasma 
matrix effects as it has been documented that the composition of plasma differs notably between animal species54. 
The LFA’s visual LoD on bovine plasma samples spiked with TcoPYK was improved 8-fold by employing bivalent 
Nb44-Nb44-AuNPs as a detecting agent (Fig. 7b). To demonstrate that the use of bivalent Nb44-Nb44-AuNPs 
would also increase the LFA’s sensitivity in an infection setting, sera of T. congolense infected mice that previously 
yielded a negative LFA result but a positive ELISA signal (Fig. 6, days 11 and 15 post-infection) were re-evaluated 
using the optimised LFA. Indeed, the visual LoD of the LFA is improved as clear bands are now visible for these 
plasma samples (Fig. 7, panels c and d).
Discussion
A large contributor for the failed eradication of many infectious diseases in developing countries is poor consul-
tation and a lack of access to diagnostic equipment. RDTs possess the potential to overcome this diagnostic gap 
in resource-limited areas55. However, RDT development for tropical diseases, such as African trypanosomosis, 
has encountered challenges of technical, infrastructural, and socio-economic nature56. One of the technical bar-
riers early on in the development of an antigen-based RDT is the inadequate characterisation of the antigen, 
the detecting and capturing antibodies, and the antigen-antibody interactions. An ideal biomarker should be 
specific, abundant, stable, quantitatively meaningful, universally present in hosts, accessible in the sample fluids, 
timely observable and well characterised57. Proteins present in a parasite’s secretome may fulfill the aforemen-
tioned requirements. The secretome represents the proteome fraction that is actively secreted by the parasite. 
However, it should be noted that some proteins found in the secretome may be present as a consequence of par-
asite death and lysis. The T. congolense secretome employed for Nb generation in this work was produced via the 
method described by Holzmuller and colleagues, which ensures a parasite viability of over 97% during secretome 
preparation58.
In this paper, we describe the identification of TcoPYK as a biomarker for T. congolense infections through the 
generation of an unbiased Nb library against the parasite’s secretome. The premise of the approach is straightfor-
ward: (i) a camelid is immunised with a parasite’s secretome, (ii) (a pair of) parasite-specific Nbs are identified and 
iii) subsequently employed to unravel the identity of the targeted antigen. Several advantages can be linked to this 
strategy. First, the Nb library is generated against native antigen(s), which enables the selected binders to recognize 
the target protein(s) with their naturally occurring post-translational modifications (if any are present). Second, 
using a protein fraction both during immunisation and phage display skews the affinity maturation and in vitro 
selection of Nbs towards those proteins that are the most abundant and/or immunogenic. This increases the likeli-
hood that eventually enough Nbs can be generated for assay development and that these Nbs detect antigen(s) that 
are present in sufficient quantities in vivo. This rationale has been applied previously using T. congolense soluble 
Cattle sera infected with
T. congolense Naive T. vivax
Positive 19 1 2
Negative 5 14 20
Total 24 15 22
Sensitivity ± 95% CI (%) 79.17 (19/24) ± 16.25
Specificity ± 95% CI (%) 91.89 (34/37) ± 8.80
PPV ± 95% CI (%) 86.36 (19/22) ± 14.34
NPV ± 95% CI (%) 87.18 (34/39) ± 10.47
Table 2. Preliminary evaluation of sensitivity, specificity, positive and negative predicted values for the Nb44/
Nb42 LFA performed on plasma samples from experimentally infected cattle. The samples were obtained from a 
stored GALVmed plasma sample collection at Clinvet, South Africa. The collection contains plasma samples of 
Holstein cows that were experimentally infected with T. vivax STIB 719 or T. congolense KONT 2/133. Because 
these animals were involved in drug development programs, they were treated as soon mild disease symptoms 
developed combined with an observed hematocrit value lower than 25%.
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proteome and has resulted in the development of a T. congolense specific homologous sandwich ELISA targeting 
glycosomal fructose-1,6-bisphosphate aldolase (TcoALD)42. However, because of the homologous nature of this 
assay, it was more challenging to translate the sandwich ELISA into an LFA. Hence, the endeavour towards devel-
oping a Nb-based LFA for T. congolense diagnosis was pursued in this work. The anti-T. congolense secretome 
Nb library yielded a Nb pair (Nb42 and Nb44) that specifically targets the glycolytic enzyme T. congolense  
pyruvate kinase (TcoPYK).
It is intriguing that yet another glycolytic enzyme is identified as a diagnostic biomarker. Other examples are 
provided by (i) Plasmodium vivax aldolase for malaria59, (ii) human pyruvate kinase, α-enolase, and triose phos-
phate isomerase for apoptosis60, (iii) and human muscle pyruvate kinase isoform 2 (PKM2) in colorectal cancer61. 
Interestingly, a significant number of reports in the recent literature describe additional non-glycolytic functions 
of glycolytic enzymes62–66. In the case of parasites, moonlighting glycolytic enzymes have been reported to be 
exposed as surface antigens67–70 or belong to the parasite’s secretome, which constitutes the fraction of parasite 
proteins released into the extracellular environment in so-called ‘extracellular vesicles (EVs)’71,72. Both TcoALD 
and TcoPYK have been shown to be part of the parasite’s secretome, which has been described for both animal 
and human trypanosomes58,73–75. In the case of trypanosomes, EVs are thought to play an important role in the 
host-parasite interaction75. How the individual secretome members affect the host-pathogen relationship remains 
enigmatic.
The observations in past reports42,59 and this work demonstrate that glycolytic enzymes can be employed as 
specific biomarkers to distinguish between species within a given parasite genus. This is surprising given the rel-
atively high degree of sequence conservation for glycolytic enzymes. For the T. congolense biomarkers identified 
by our group (TcoALD42 and TcoPYK identified in this work) the sequence identities with TbrALD and TbrPYK 
are 94.1% and 88.0%, respectively. For the Nb-based T. congolense immunoassay targeting TcoALD42, we have 
recently shown that the molecular basis for specificity lies in the assay’s homologous sandwich design76. In the 
case of the Nb44/Nb42 assays, the reasons for their high T. congolense specificity remain unclear. The charac-
terisation of the Nb-TcoPYK interactions performed in this work reveals two features of the Nb44/Nb42 assays. 
First, the Nb pair only works in a unidirectional manner. When Nb44 and Nb42 are employed as capturing and 
detecting Nbs, respectively, both the ELISA and LFA display a clear signal. However, when the roles of both Nbs 
are swapped, no signal is observed. Second, a tripartite (Nb44)2: (TcoPYK)4: (Nb42)4 complex can be generated, 
suggesting that both Nbs bind distinct, non-competing epitopes. In the absence of further detailed studies of 
these interactions, the molecular basis for the assay’s specificity and unidirectionality remains yet unknown.
The Nb44/Nb42 pair was first tested in the format of a heterologous sandwich ELISA. In order to limit the 
number of assay steps, Nb42HA was replaced by its biotinylated counterpart Nb42B. The LoD of the Nb44/
Nb42 ELISA (using Nb42B and strep-HRP) could be improved by a factor 32 by optimising the valency of the 
capturing agent Nb44 and the properties of the streptavidin-enzyme conjugate used for assay development. These 
Figure 7. The Nb44/Nb42 LFA can be employed to detect experimental T. congolense infections in cattle. (a,b) 
LFA read-outs for naive cattle serum spiked with a dilution series of TcoPYK using monovalent Nb44-AuNPs 
(a) and bivalent Nb44-Nb44-AuNPs (b). In both cases, the samples were diluted three-fold in PBS containing 
1% methylcellulose and 1% Tween20. (c,d) LFA read-outs for sera from mice infected with T. congolense 
using monovalent Nb44-AuNPs (c) and bivalent Nb44-Nb44-AuNPs (d). In both cases, the samples were 
diluted three-fold in PBS containing 1% methylcellulose and 1% Tween20. In all LFAs, the test line consists of 
a streptavidin-based coating of biotinylated Nb42. The visual LoD was established based on the last TcoPYK 
concentration at which a TL band could be observed (indicated by the black arrow). 50 μl of sample was spotted 
onto the sample pad.
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modifications highlight the versatility of Nbs as detection tools. Because of their small size, they can easily be 
incorporated into multivalent and/or tagged constructs48 to overcome significant limitations. In this case, the 
gain in sensitivity obtained via the bivalent Nb44-Nb44 construct is probably due to an increased apparent affin-
ity of the Nb-antigen interaction through avidity. In an experimental mouse model, the optimised heterologous 
Nb44-Nb44/Nb42 ELISA detects target antigen as soon as 4 days post-infection. More importantly, TcoPYK 
could not be detected in animals that were cleared of infection through Berenil treatment (clearance as soon as 
24 h post-treatment occurred in most of the mice). Hence, it seems that living parasites are required in order for 
the target antigen to be detected by the Nb44-Nb44/Nb42 ELISA. It should be noted that, throughout the experi-
ments, the absence of a linear correlation between the antigen levels in blood and the parasitaemia was observed 
(i.e. high levels of parasitaemia do not necessarily correspond to high OD values in ELISA). This is due to a 
multitude of uncertainties (and/or untraceable events): (i) containment of antigen in the blood stream (present 
in EVs and/or freely circulating protein in blood; ratio between free and vesicular antigen remains unknown) (ii) 
fitness of the parasite and amount of antigen released; (iii) likely differential clearance from blood of free antigen 
and vesicular antigen; (iv) involvement of the host immune system in clearing the antigen (e.g. via host antibod-
ies against TcoPYK and/or effect of inflammation on clearance); (v) the antigen dynamics: the balance between 
antigen release in the blood and its clearance rate via multiple pathways (hepatic versus renal clearance), etc. 
Nonetheless, the above-mentioned results suggest that the Nb44-Nb44/Nb42 ELISA may serve as a test-of-cure 
application during drug screening programs or in follow-up field studies after treatment with a commercial drug. 
Additionally, given that the Nb44-Nb44/Nb42 ELISA is highly specific for T. congolense, it could be a valuable 
tool to accurately determine the prevalence and incidence of T. congolense infections in epidemiology studies.
While the ELISA can be used in a standard laboratory environment, a complementary RDT is necessary 
for faster decision making in rural areas. The LFA format is a highly suitable one for use under field conditions 
when it complies with the ASSURED criteria19. While procedures to couple conventional antibodies to AuNPs 
for a visual read-out are well established, manufacturing Nb-AuNP conjugates is less straightforward. Recently, 
we demonstrated that more acidic Nbs possess the right charge balance to generate stable Nb-AuNP conjugates 
through physical adsorption49. Since Nb42 and Nb44 (i) are relatively acidic (pI values of 6.42 and 5.55, respec-
tively), and (ii) bind distinct TcoPYK epitopes, the heterologous sandwich ELISA could be translated into an LFA. 
The unidirectionality of the Nb44/Nb42 pair imposes the roles of the Nbs in the LFA format. Nb44 should be 
used as the detection agent and to generate stable Nb-AuNPs, which is convenient since it is the most acidic Nb49. 
Nb42 should be used as the capturing agent and immobilised on the test line. A streptavidin-based immobilisa-
tion method (also preferred by others41) was chosen for this purpose as this improves the analytical sensitivity. 
This is probably due to a better orientation of the capturing Nb which improves antigen recognition and an 
increased immobilisation efficiency on the nitrocellulose membrane since it is known some small proteins do not 
adhere easily onto the surface material77. The detection label, pads and membranes constituting the LFA strips 
were standard as more complicated material, design and alternative labelling strategies would raise manufactur-
ing costs and diminish speed and user-friendliness78. The Nb44/Nb42 LFA was first tested and optimised on mice 
sera spiked with TcoPYK and subsequently tested in the mouse infection trials. Compared to the Nb44/Nb42 
ELISA, the LFA seems to possess a higher false negative rate during early infection stages, when parasites are 
barely present in the host’s blood. Most likely this is due to a technical limitation of the LFA format as a detection 
system rather than a failure of the Nbs to capture low quantities of analyte in T. congolense infected blood. The 
Nb44/Nb42 ELISA, which is based on the same Nb pair as the LFA, might display a higher sensitivity because of 
longer incubation times and an enzyme-mediated signal amplification step.
Finally, the LFA was also tested on serum samples from cattle experimentally infected with T. congolense. This 
initial study shows that the Nb44/Nb42 LFA in its current format could be useful for cattle screening at the herd 
level. In addition, given the high specificity of the test (92%), a positive score would allow for a reliable decision 
making in anti-trypanosomosis treatment. As future perspective, the LFA described here could be amenable 
to further optimisation to allow its use for decision making based on single individual cattle screenings. Our 
first efforts to increase the LFA’s sensitivity in cattle samples entails employing AuNPs coated with the bivalent 
Nb44-Nb44 construct. In future work, this could be improved even further by optimizing the composition of the 
assay buffer to overcome the ‘plasma matrix effect’ associated with cattle sera54. In conclusion, we have paved the 
road towards developing the first Nb-based LFA for the specific diagnosis of active T. congolense infections via 
detection of a parasite antigen (pyruvate kinase). After further development, the Nb44/Nb42 LFA will be evalu-
ated in a large field study to assess the assay’s true performance (NPV and PPV) as an RDT in a realistic setting.
Methods
Ethical statement. All animal experiments were carried out according to directive 2010/63/EU of the 
European parliament for the protection of animals used for scientific purposes and approved by the Ethical 
Committee for Animal Experiments of the Vrije Universiteit Brussel (clearance numbers 14-220-8 and 14-220-9).
Bovine serum/plasma samples used in this study were kindly provided by Galvmed and tested in Clinvet 
research innovation (Bloemfontein, South Africa). 62 samples from experimentally infected Holstein cows were 
analysed using the LFA. These samples include pre-infected samples (n = 15), T. vivax STIB 719 infected samples 
(n = 22) and T. congolense KONT2/133 infected samples (n = 25).
Nb library construction and phage display onto T. congolense secretome. Secretomes from two 
different T. congolense strains (IL3000 and IL1180) were kindly provided by Dr. Philippe Holzmuller (CIRAD 
Montpellier, France). Secretomes were prepared as previously described73. The details of alpaca immunisation, 
Nb library generation and panning, Nb cloning, production, and purification are given in the Supplementary 
Information file accompanying this article.
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Antigen identification by LC-MS. The target antigen recognised by the Nb44/Nb42 sandwich was isolated 
through an immuno-capturing experiment. Five hundred g T. congolense IL3000 secretome was mixed with 25 μg 
Nb42H in a final volume of 300 μl PBS. The mixture was incubated for 2 h at 22 °C. The Nb-antigen complex 
was isolated using the QuickPick™ IMAC kit (Bio-Nobile) following the kit instructions provided by the man-
ufacturer. Aliquots of 20 μl from each purification step were collected and resolved under reducing conditions 
on SDS-PAGE using 10% precast polyacrylamide gels (NuPAGE Bis-Tris gels, Thermo scientific), followed by 
Coomassie-blue staining. The band of interest was excised from the SDS-PAGE gel and analysed by LC-MS/MS 
spectrometry as described42.
Production and purification of TcoPYK, TbrPYK and LmePYK. The genes encoding pyruvate 
kinase of T. congolense (TcoPYK, Genbank NCBI ID: CCC94421), T. brucei brucei (TbrPYK, Genbank NCBI 
ID: X57950) and L. mexicana (LmePYK, Genbank NCBI ID: X74944) were codon optimised for expression in E. 
coli. Gene synthesis and cloning were performed by GenScript. Briefly, the synthesised genes were cloned into 
pET21b vector (Novagen) using the NdeI and XhoI restriction sites. All genes were designed such to equip the 
resulting protein products with a C-terminal protease cleavage site (TEV) and a His-tag. The three constructs 
were transformed into E. coli BL21(DE3) cells using the electroporation method. Transformed cells were plated 
on LB agar plates supplemented with 2% glucose and 100 μg ml−1 ampicillin. The details for protein production 
and purification are given in the Supplementary Information file accompanying this article.
Surface plasmon resonance. Surface plasmon resonance (SPR) experiments were performed on a 
BIAcore T200 system (GE Healthcare). A detailed explanation of the experimental set-up is provided in the 
Supplementary Information file accompanying this article.
ELISA. Depending on the goal of the experiment, the plates were coated with different capturing material (see 
different ELISA variants described in the Supplementary Information file accompanying this article). The coated 
plate was incubated overnight at 4 °C and the excess of non-coated material was removed by washing the plate 
three times with PBS containing 0.01% Tween20 (PBS-T). Next, blocking of residual protein binding sites was 
performed by adding 300 μl blocking buffer (5% milk powder in PBS) to each well and the plate was kept for 2 h at 
room temperature. Subsequently, the plate was washed three times with PBS-T, after which samples were allowed 
to interact with the capturing material. After incubation for 1 h at room temperature, the plates were subsequently 
washed three times with PBS-T. Then, 100 μl primary detection reagent was added to the plates at the appropriate 
concentration. The plates were incubated for 1 h at room temperature and subsequently washed 5 times with 
PBS-T. The secondary antibody, 100 μl of streptavidin-HRP conjugate (Jackson ImmunoResearch laboratories; 
diluted to a concentration of 0.5 μg ml−1 in protein-free blocking buffer (ThermoFischer Scientific)), was then 
added to the plate, followed by incubation for 1 h at room temperature. After a final washing step (5 times with 
PBS-T), the ELISAs were developed by addition of 100 μl of 3,3′,5,5′-tetramethylbenzine (TMB) substrate and 
subsequent incubation for 25 min at room temperature. The enzymatic reaction was stopped by adding 50 μl 
1 M H2SO4 to the reaction mixture. The plates were read at OD450nm with a VersaMax ELISA Microplate Reader 
(Molecular Devices).
TcoPYK lateral flow assay manufacturing. The LFA gold pad is developed from polyester (VL98 
from Shanghai Kinbio Tech. Co., Ltd. Shanghai, China). The nitrocellulose membrane has a capillary flow of 
135 s 4 cm−1 (HF135, EMD-Millipore). The sample pad consists of glass fibre (Shanghai Kinbio Tech. Co., Ltd. 
Shanghai, China). Gold nanoparticles were prepared via citrate reduction of hydrogen tetrachloroaurate accord-
ing to according to established protocols79,80. 66 μM of Nb44 or Nb44-Nb44 was adsorbed for 30 min onto 100 ml 
of pH adjusted gold particles (using 0.2 M K2CO3). Next, the particles were blocked 20 min with 1% BSA (MilliQ). 
The particles were concentrated 20x through centrifugation (17.000 g, 30 min.), sprayed onto pre-treated gold pad 
membranes (4 μl cm−1) with the Biodot XYZ3060 dispense platform and dried overnight at 37 °C. Meanwhile a 
test line was applied with the Biodot dispenser onto a nitrocellulose membrane using a 2:1 molar ratio of Nb42B 
(1 mg ml−1) and Streptavidin (0.5 mg ml−1) (Sigma), dissolved in 3% trehalose. For the control line goat monoclo-
nal anti-rabbit IgG was used (1 mg ml−1 in 3% trehalose). As a control gold conjugate, 1 mg of polyclonal rabbit 
IgG per 100 ml gold particles was prepared as described before. The LFA strips (width 4 mm) were assembled and 
put into plastic cassettes.
Comparison between TcoPYK ELISA, TcoPYK LFA and microscopy as survey tools on T. congo-
lense infected mice. C57BL/6 mice (n = 9) were inoculated intraperitoneally with 5000 T. congolense (Tc13) 
parasites. The mice were bled at different times post-infection (day 3, 7, 11, 15, 19, 23, 27, 31 and 35). During each 
time point 100 μl of whole blood was collected from the tail of each individual using heparin-coated capillary 
tubes. Two μl of blood was used to follow-up mice parasitaemia by diluting the sample 100-fold (during high 
parasitaemia periods) or 50-fold (low parasitaemia periods) in RPMI medium and counting the parasites under 
the light microscope. The rest of the blood was centrifuged at 1500 g for 10 minutes. Plasma was collected and 
tested in the ELISA and the LFA. For the ELISA, 30 μl of plasma was diluted in 60 μl of PBS-T, while for the LFA 
20 μl plasma was diluted in 40 μl PBS-T containing 1% methylcellulose (Sigma) per sample and applied onto the 
sample pad. After maximum 20 minutes, the result could be read from the test line. ELISA, LFA and microscopy 
results were compared measuring the inter-rater reliability between tests through the Cohen’s kappa coefficient81.
TcoPYK sandwich ELISA and LFA during T. congolense treatment follow-up in mice. The PYK 
antigaenemia during the course of a T. congolense infection in mice before and after diminazene aceturate treat-
ment (Berenil by CEVA) was assessed using the Nb44-Nb44/Nb42 sandwich ELISA and the TcoPYK LFA. 
C57BL/6 mice were divided in three groups of six individuals each. In each group, five mice were inoculated 
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intraperitoneally with 5000 T. congolense (Tc13) parasites. The remaining mouse in each group was used as a naive 
negative control. All individuals from group 1 and 2 were treated with Berenil (20 g per kg animal) administered 
intraperitoneally at day 6 (group 1) and day 14 (group 2) post-infection, while group 3, remained untreated dur-
ing the course of infection. Mice were bled at different times points before and after infection (day −1, 4, 7, 10, 13, 
16, 19 and 22). The bleeding, ELISA, microscopy and LFA analysis are performed as described before.
TcoPYK LFA to diagnose cattle experimentally infected with T. congolense. Frozen bovine 
plasma samples (−80 °C) were kindly provided by Clinvet (Bloemfontein, South-Africa). The original blood sam-
ples were collected at different time points during an experimental trypanosome infection whereby 22 Holstein 
cows were injected with T. congolense Savannah-type KONT 2/133 (isolated in 2004 from naturally infected cattle 
in Cameroon, stabilate from Belgian Tropical Institute of Medicine) and 22 Holstein cows were injected with 
T. vivax STIB 719 (isolated as Y486 strain in 1976 from naturally infected cattle in Nigeria, stabilate from Swiss 
Tropical and Public Health Institute). Pre-infected samples served as the naive control samples. Of each sample, 
20 μl plasma was diluted in 40 μl PBS-T containing 1% methylcellulose (Sigma) and applied onto the sample pad 
of the LFA. After maximum 20 minutes, the result could be read visually from the test line.
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